This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will present at two upcoming investor conferences:
RBC Capital Markets 2013 Global Healthcare Conference
Tuesday, February 26
th at 8:00 AM Eastern Time New York Palace Hotel, New York City
Cowen & Company 33rd Annual Health Care Conference
Tuesday, March 5
th at 9:20 AM Eastern Time The Boston Marriott Copley Place, Boston
A live webcast of the presentations will be available on the Sunesis website at
http://ir.sunesis.com . A replay of the webcasts will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis, please visit
For additional information on Sunesis, please visit
The Sunesis Pharmaceuticals, Inc. logo is available at
The VALOR logo is available at
CONTACT: Investor and Media Inquiries:
Sunesis Pharmaceuticals Inc.
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.